We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Established in 2006, Huarong Industrial Group Limited is a specialist in the supply of Pharmaceutical intermediates, Active Pharmaceutical Ingredients (APIs), fine chemicals and in both R&D and commercial quantities. With experience of 11 years in devotion to developing, manufacturing, sourcing and exporting to serve high quality products, Huarong Industrial keeps pace with the forefront of this constantly changing industry. Huarong Industrial set up a R&D centre in 2009 to provide service of custom synthesis and new product development. In the mean time, we have formed a Regulatory Department in order to support domestic pharmaceutical manufacturers of partnership for API registration in overseas market and to assist our international clients for Chinese factories' field audit. Huarong Industrial is in continuous pursuit of providing an unparalleled supply and sourcing service based on flexibility and diversity of operations. Currently, we have a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients around the world.
Three years of qualification
Audited Supplier
![tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxyla](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_03/Mimg_1703230522333841.jpg!200)
![3-Methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_03/Mimg_1703230526861544.jpg!200)
![(4S)-3-[(5S)-5-(4-Fluoro phenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_03/Mimg_1703230522254360.jpg!200)
![(1S,3aR,6aS)-Octahydro-cyclopenta[c]pyrrole-1-carboxylic acid ethyl ester hydrochloride](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_03/Mimg_1703230515356934.jpg!200)
![4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_03/Mimg_1703230522336094.jpg!200)
Pharma Sources Insight JANUARY 2024
